About Genetesis
Genetesis is a Healthcare company based in Mason (United States) founded in 2013 by Emmanuel Setegn, Vineet Erasala, and Peeyush Shrivastava. Developer of a medical imaging device for the diagnosis of cardiac conditions. Genetesis has raised $35.48 million across 6 funding rounds from investors including Wilson Sonsini Goodrich & Rosati, Mithril and Cercano Management. The company has 28 employees. Its chief executive, as recorded, is Peeyush Shrivastava. Genetesis offers products and services including CardioFlux and CardioFlux Membership. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Screening Devices. Its legal entity is GENETESIS, INC.
Company details
Genetesis was founded in 2013 and is headquartered in Mason, United States. The company operates in the medical imaging sector, focusing on cardiac diagnostics. A device named CardioFlux is being developed to utilize magnetocardiography for measuring the hearts natural magnetic fields. This technology aids in the non-invasive assessment of cardiac conditions, with operations centered on device innovation and clinical applications.
- Headquarters Mason, United States
- Employees 28
- Founders Emmanuel Setegn, Vineet Erasala, Peeyush Shrivastava
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Website genetesis.com
- Social LinkedIn X Facebook Instagram
- Legal Name Genetesis, Inc.
- Total Equity Funding$35.48M (USD)
in 6 rounds
- Latest Funding Round$17.5M (USD), Series C
Oct 2022
- InvestorsWilson Sonsini Goodrich & Rosati
& 11 more
- Employee Count28
Products & Services of Genetesis
Genetesis offers a comprehensive portfolio of products and services, including CardioFlux and CardioFlux Membership.
Non-invasive tool for early detection of myocardial ischemia in hospitals.
Program offering access to preventive cardiac care tools and resources.
Funding Insights of Genetesis
Genetesis has successfully raised a total of $35.48M across 6 strategic funding rounds. The most recent funding activity was a Series C round of $17.5 million completed in October 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $35.48M
- Total Rounds 6
- Last Round Series C — $17.5M
- First Round $250,000
(Oct 2014)
- Investors Count 12
All 6 funding rounds of Genetesis with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2022 | $17.5M | Series C | – | Mithril | |
| Oct 2021 | $75,000 | Series B | – | HealthTech Arkansas | – |
| Apr 2020 | $9.2M | Series B | – | TDK Ventures | |
| Jun 2018 | $7.5M | Series A | – | CincyTech | |
| Jun 2016 | $1.2M | Seed | – | CincyTech | |
| Oct 2014 | $250,000 | Grant | – | – |
12 investors in total: 11 institutional and 1 angel.
Investors in Genetesis
Genetesis has secured backing from 12 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Wilson Sonsini Goodrich & Rosati, Mithril and Cercano Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments are made in the UK and US. | mithril.com | Austin, United States | ||
Early-stage sector-agnostic VC firm investing in geographies such as the US | ohioinnovationfund.com | Columbus, United States | ||
CincyTech is engaged in venture capital investments for innovative startups. | cincytechusa.com | Cincinnati, USA | ||
HealthTech Arkansas is focused on driving healthcare innovation in Arkansas. | healthtecharkansas.com | United States | ||
Early-stage tech startups are invested in globally by TDK Ventures. | tdk-ventures.com | San Jose, United States | ||
Investment and strategic support are provided by Raptor Group. | raptorgroup.com | Boston, United States | ||
LOUD Capital is focused on alternative investments for social impact. | loud.vc | Dublin, USA | ||
Seed-stage investments are targeted by 43North in startups. | 43north.org | Buffalo, United States | ||
Provides investment advisory services to ultra-high-net-worth individuals and families. | 2021 | cercanolp.com | Bellevue, United States | |
JobsOhio is focused on economic development in Ohio. | jobsohio.com | Columbus, United States |
Investor details for Genetesis
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Genetesis
23 people are tracked at Genetesis (7 in leadership, 8 in board & advisors, 8 in team); the tracked headcount is 28.
| Name | Role | Group |
|---|---|---|
Emmanuel Setegn | Co-Founder & CTO | Leadership |
Vineet Erasala | Co-Founder & COO | Leadership |
Peeyush Shrivastava | Co-Founder & CEO | Leadership |
Ryan Yoo | Director of Product Marketing | Leadership |
Robert Sokolowski | VP, Clinical, Quality & Regulatory Affairs | Leadership |
Eric Lee | VP of Finance & Accounting | Leadership |
Chandan Srivastava | Co-founder | Leadership |
W Frank Peacock | Scientific Advisor | Board & advisors |
Bill Baumel | Board Member | Board & advisors |
Mark Cuban | Board Member | Board & advisors |
Margarita Pena | Scientific Advisor | Board & advisors |
Sajid Malhotra | Chairman Of The Board | Board & advisors |
Alexander Ding | Scientific Advisor | Board & advisors |
Viviany Taqueti | Scientific Advisor | Board & advisors |
Simon Mahler | Scientific Advisor | Board & advisors |
Cliff Uber | Electrical Engineer II | Team |
Ben Moore | Technical Product Manager | Team |
Redi Llapi | Senior Research And Development Engineer | Team |
Marci Collier | Staff Accountant | Team |
Melanie Gruen | Clinical Project Manager | Team |
3 more people are available in the full profile.
Complete people profiles for Genetesis
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Genetesis
3 dated milestones of Genetesis across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Genetesis is founded.
- Funding First funding round of $250K.
- Funding Latest funding round, Series C, of $17.5M.
Web traffic of Genetesis
The website of Genetesis (genetesis.com) receives about 2.1K visits a month and ranks #6,032,983 among all websites worldwide, #6,378 in Biotechnology and Pharmaceuticals.
- Monthly visits2.1K
▼ 21% vs previous month
- Unique visitors1.2K
per month
- Global rank#6,032,983
among all websites
- Category rank#6,378
Health · Biotechnology and Pharmaceuticals
- Bounce rate42%
- Pages per visit1.8
- Average visit32 sec
- DevicesDesktop 39% · Mobile 61%
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as Genetesis (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Genetesis
Complete news archive for Genetesis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genetesis
Genetesis was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Genetesis is headquartered in Mason, United States. It is registered at Mason, Ohio, United States.
Peeyush Shrivastava is the CEO of Genetesis, as recorded in our data. They have also founded this company.
Genetesis is a funded company, having raised a total of $35.48M across 6 funding rounds to date. The company's 1st funding round was a Grant of $250K, raised on Oct 2014.
Genetesis has 28 employees.
Genetesis was founded in 2013 and is headquartered in Mason, United States. The company operates in the medical imaging sector, focusing on cardiac diagnostics. A device named CardioFlux is being developed to utilize magnetocardiography for measuring the hearts natural magnetic fields. This technology aids in the non-invasive assessment of cardiac conditions, with operations centered on device innovation and clinical applications.
Genetesis offers CardioFlux and CardioFlux Membership.
Genetesis has 12 investors. Key investors include Wilson Sonsini Goodrich & Rosati, Mithril, Cercano Management, JobsOhio, and Ohio Innovation Fund.
Genetesis operates through Genetesis, Inc..